In a recent study published in the journal Nature Communications, researchers present a method for constructing artificial viral vectors (AVVs) using the established structural components of ...

But many things can go wrong in this process. One main issue is that these gene therapy vehicles can travel to the wrong places and damage healthy cells. Now, scientists think that a type of virus ...

The tail of bacteriophage T4 is shown before (left) and after (right) binding to a host cell. Upon attachment to the bacterium, the bacteriophage pierces the host cell envelope and injects its genomic ...

Venigalla B. Rao, PhD, has been studying bacteriophages for more than four decades, mostly in small laboratories with limited personnel and funding. But having a mere eight-person lab (four post-docs, ...

Researchers have learned how the bacterial virus, bacteriophage T4, attacks its host, the E. coli bacterium. This discovery could eventually lead to a new class of antibiotics. Funded primarily by the ...

These self-propelling microscopic particles use tailor-made viruses to recognize specific bacteria strains. The viruses bind to matching bacteria to form unique sandwich structures that are then ...

New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. New research shows that a needle-free mucosal bacteriophage ...

(Nanowerk News) International researchers have built artificial virus-like particles capable of entering human cells to perform tasks such as gene editing. In a proof of concept study, the team used a ...

In a recent study posted to bioRxiv* preprint server, researchers developed a mucosal vaccine for coronavirus disease 2019 (COVID-19) based on bacteriophage. Vaccines against severe acute respiratory ...

Aims: Novel anticancer strategies have employed bacteriophages as drug carriers and display platforms for anticancer agents; however, bacteriophage-based platforms maintain their natural antibacterial ...